HIV Testing - 2c - Info Sheet

Community Health Awareness Group Evaluation

“Demonstration Project of HCV Rapid Testing in HIV Testing Settings”

Attachment 2c . Staff and Client Interview and Focus Group Information Sheet

Evaluation Research Information Sheet

Title of Study: Community Health Awareness Group (CHAG):

Demonstration Project of HCV Rapid Tests in HIV Testing Settings

Principal Investigator (PI): Julie Gleason-Comstock, PhD

Center for Urban Studies, Office of the Provost (313 577-9143)

Funding Source: CHAG and Centers for Disease Control

Purpose:

You are being asked to be in an evaluation research study to evaluate program effectiveness for CHAG because you participate in one or more of CHAG community outreach, prevention, education and care services. This study is being conducted at community sites throughout Southeastern Michigan. The purpose of the study is to better understand the needs of persons at risk for Hepatitis C (HCV), focusing on men and women and their partners.

Study Procedures:

You are being asked to participate because you are participating in one or more of CHAG outreach, prevention, education or care programs. You are being asked to voluntarily participate in key informant interviews and role plays, and focus groups about your perceptions of HCV risks. The interviews and focus groups will be conducted by CHAG program staff. No participant names will be used in the focus group, or role plays/ informant interviews. The focus group will be audio taped, transcribed and the tape will be destroyed by the agency after transcription.

Benefits

As a participant in this research study, there may be no direct benefit for you; however, information from this study may benefit other people now or in the future.

Risks

There are no known risks at this time to participation in this study.

Costs

There will be no costs to you for participation in this research study.

Compensation

For taking part in this research study, you will receive$20 as a token of appreciation from CHAG for each focus group and role play/ informant interview.

Confidentiality

The study will be anonymous and there will be no list linking your identity to a code name or number.

Voluntary Participation /Withdrawal

Taking part in this study is voluntary. You may leave the study at anytime.

Questions:

If you have any questions about this study now or in the future, you may contact Julie Gleason-Comstock or one of her research team members at the following phone number (313-577-9143). If you have questions or concerns about your rights as a research participant, the Chair of the Human Investigation Committee can be contacted at (313) 577-1628. If you are unable to contact the research staff, or if you want to talk to someone other than the research staff, you may also call (313) 577-1628 to ask questions or voice concerns or complaints.

Participation:

By participating in the brief survey, role play and informant interviews you are agreeing to participate in this study.

Submission Date: May 20, 2011 Page 1 of 1

Protocol Version #: 1

HIC Date: 5/08